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Objective:  Informed  decision  making  requires  transparent  and  evidence-based  (=balanced)  information
on  the  potential  beneﬁt  and  harms  of medical  preventions.  An analysis  of German  HPV  vaccination  leaﬂets
revealed,  however,  that  none  met  the  standards  of  balanced  risk  communication.
Methods: We  surveyed  a  sample  of  225  girl–parent  pairs  in a  before–after  design  on  the  effects  of  bal-
anced  and  unbalanced  risk  communication  on participants’  knowledge  about  cervical  cancer  and  the
HPV  vaccination,  their  perceived  risk,  their  intention  to have  the  vaccine,  and  their actual  vaccination
decision.
Results:  The  balanced  leaﬂet  increased  the  number  of participants  who  were  correctly  informed  about
cervical  cancer  and  the  HPV  vaccine  by 33  to  66  absolute  percentage  points.  In contrast,  the  unbal-
anced  leaﬂet  decreased  the number  of participants  who  were  correctly  informed  about  these  facts
by  0  to  18 absolute  percentage  points.  Whereas  the  actual  uptake  of  the  HPV  vaccination  14 months
after  the  initial  study  did  not  differ  between  the  two groups  (22%  balanced  leaﬂet  vs. 23% unbalanced
leaﬂet;  p  = .93,  r =  .01),  the  originally  stated  intention  to have  the  vaccine  reliably  predicted  the  actual
vaccination  decision  for  the  balanced  leaﬂet  group  only  (concordance  between  intention  and  actual
uptake:  97%  in  the  balanced  leaﬂet  group,  rs = .92,  p =  .00;  60%  in the  unbalanced  leaﬂet  group,  rs =  .37,
p  =  .08).
Conclusion: In contrast  to a unbalanced  leaﬂet,  a balanced  leaﬂet  increased  people’s  knowledge  of
the  HPV  vaccination,  improved  perceived  risk judgments,  and  led  to  an  actual  vaccination  uptake,
which  ﬁrst  was  robustly  predicted  by people’s  intention  and  second  did  not  differ from  the uptake
in  the unbalanced  leaﬂet  group.  These  ﬁndings  suggest  that  balanced  reporting  about  HPV  vaccina-
tion  increases  informed  decisions  about  whether  to  be  vaccinated  and  does  not  undermine  actual
 201
uptake.
©
. Introduction
Unbalanced reporting is a recognized issue in the commu-
ication of medical facts [1,2]. It ranges from incomplete and
ontransparent information (e.g., omitting potential harms, repor-
ing relative risk instead of absolute risk reduction/increase) to
ctive persuasion [3–8]. As the “pill scare” in the United Kingdom
ocuments, misinforming patients through unbalanced repor-
ing can have dramatic consequences. In 1995, after the U.K.
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Committee on Safety for Medicine stated that the risk of throm-
boembolism doubles when taking the third generation of the
oral contraceptive pill compared to the second generation, many
women stopped taking the pill [9]. Results were unwanted preg-
nancies and an estimated increase of 13,000 abortions in the
following year [10]. The message of “double the risk”, which scared
so many women, was in fact based on the following absolute num-
bers: 1 in 7000 women  who took the second generation pill suffered
from thromboembolism compared to 2 in 7000 who  took the third
generation pill [1]. If the U.K. Committee had used these absolute
numbers to communicate the risk increase, many women might
have reacted differently and been saved from unwanted pregnan-
cies and abortions.
Open access under CC BY-NC-ND license.Although ethical policies in Germany and elsewhere increas-
ingly stipulate that participation in medical prevention should
reﬂect informed choice, particularly because prevention targets
healthy people [11], this has not yet been translated into practice.
 license.
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or instance, a recent study [3] published in Vaccine revealed
nbalanced reporting in the German coverage of the human papil-
omavirus (HPV) vaccination, which has been recommended and
overed by German health authorities since March 2007 for girls
ged 12–17 years. To determine what counts as unbalanced and
alanced reporting, the authors of that study identiﬁed the follow-
ng criteria as standards of good risk communication [3]:
1)  Completeness (baseline risk of cervical cancer, beneﬁt and harms
of  vaccination)
2) Transparency (presentation of all risk information in abso-
lute  numbers, not relative numbers; provision of a reference
class)
3) Correctness (evidence-based information)
It  and a further study [3,4] documented that both leaﬂets from
erman health agencies and the media provide incomplete infor-
ation about the risk of cervical cancer and the vaccination’s
ffectiveness and use nontransparent statistics to communicate
he beneﬁt and harms of vaccination. None of the studied leaﬂets
rovided correct and transparent numbers on the effectiveness of
PV vaccination, and more than 60% did not mention any harms
t all related to the vaccine [4]. Until now, it had not been studied
hether and how unbalanced reporting on HPV vaccination affects
he target persons.
.  Aims of the study
The  current study sought to learn how balanced versus unbal-
nced information about HPV vaccination inﬂuences (1) girls’ and
arents’ knowledge of the risk of cervical cancer and the effec-
iveness of the HPV vaccine (both being the basis for informed
ecisions), (2) their perceived risk of developing cervical cancer
ithout having the HPV vaccine, (3) the intention to have the vac-
ine, (4) the actual vaccination decision, and (5) the phenomenon
f the “knowledge–behavior gap”.
In accordance with results from current research, we  hypoth-
sized that balanced health information would increase people’s
nowledge [12–14] about the risk of the disease and the effec-
iveness of the vaccine, reduce people’s perceived risk of getting
ervical cancer without having the HPV vaccine, and reduce
heir intention to have the HPV vaccine [15–17]. Little is known,
owever, about how balanced information inﬂuences the actual
accination decision. In a study by Steckelberg and colleagues [18]
nvestigating the effect of evidence-based risk information about
olorectal cancer screening on people’s knowledge and screening
ecision, the authors found increased knowledge about the efec-
iveness of the screening but no undermining effect on people’s
creening intentions or actual screening decision. Previous research
as already discovered incongruities between people’s knowledge
nd their actual health behavior (e.g., [19,20]). Terms such as the
knowledge–behavior gap” have been coined for this phenomenon,
here medical education interventions were found to improve
eople’s knowledge without altering their behavior (e.g., [21,22]).
o the best of our knowledge, however, none of the studies on the
nowledge–behavior gap accounted for the fact that information on
he same medical topic can be presented in different formats, which
ay  affect the phenomenon differently. Our study was  designed to
nable examination of whether balanced or unbalanced informa-
ion indeed affect the correspondence of knowledge and behavior
ifferently. If participants’ knowledge and their actual vaccination
ecisions were found to be uncorrelated under each condition, this
ould suggest that other mechanisms (e.g., following the “trust-
our-doctor” heuristic [23]) than the information format inﬂuence
accination decisions. If participants’ knowledge and their actual32 (2014) 1388–1393 1389
vaccination  decisions were found to be correlated in one or the
other setting, this would suggest that the knowledge–behavior gap
depends on how information is presented.
3. Method
3.1. Participants
The focus of the study was  on parents and girls. Because we
wanted to investigate participants’ views before exposure to the
HPV vaccination, we recruited all girls from 6th-grade classes at
German secondary schools at the beginning of the school year. To
ensure socioeconomic diversity of the sample, we  chose a con-
venience sample of 16 secondary schools from eight districts in
Berlin. All participants who  showed interest in the study gave their
consent; for the girls we requested written consent from one of
their parents. Participation rates per school varied between 57%
and 85%. Altogether, we  collected 225 complete girl–parent data
sets (balanced leaﬂet: n = 122, unbalanced leaﬂet: n = 103). Within
the parent sample, 95% of the 225 participants were mothers, the
mean age was  41.4 (SD: 5.3), and 91% had at least a high-school
degree.
4. Material
Leaﬂets. In the unbalanced leaﬂet group, participants received
a leaﬂet from a major German cancer organization (Deutsche
Krebshilfe) that did not meet the criteria of balanced risk
communication as outlined above (see Table 1). In the bal-
anced leaﬂet group, participants received a leaﬂet that was
based on the facts box for Gardasil (see Table 2), recently
published in Vaccine [3] and in Bundesgesundheitsblatt [4].
The balanced and unbalanced leaﬂets (in German) are acces-
sible via http://www.harding-center.com/HPV/study materials.
Tables 1 and 2 describe the content of each leaﬂet with respect to
each of the criteria outlined earlier as necessary for balanced risk
communication.
4.1. Survey procedure
Our  study was  conducted between January and March 2010 in
Germany. Girls were visited in their classrooms on a predetermined
date; parents received their study materials via their daughters and
completed the study alone. After the girls were explained the pur-
pose and procedure of the study, they were randomly assigned to
either the balanced leaﬂet group or the unbalanced leaﬂet group.
Each girl was then asked to complete the ﬁrst part (before leaﬂet)
of the survey, subsequently received the respective leaﬂet to read,
and then worked through the second part (after leaﬂet) of the sur-
vey. After completion, each girl was  given an envelope for their
parent that contained instructions for the study, a survey, and a
leaﬂet. Parents were assigned to the same group as their daugh-
ter (balanced leaﬂet or unbalanced leaﬂet). We  asked the girls to
return the completed materials from their parents to school within
3 days. For each complete data set (survey of girl and parent),
participants were given a 15-euro Amazon voucher. Seventy-two
percent of all contacted parents returned their survey, and 59% of
them agreed to be recontacted about a year later for the second
part of the study investigating the actual HPV vaccination deci-
sion.4.2. Survey
The survey took the following outcome measures: knowledge
of cervical cancer; knowledge of the purpose, beneﬁt, and harms
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Table 1
Information provided in the leaﬂet from one of Germany’s Major Cancer Organizations, Deutsche Krebshilfe, Chosen as the Unbalanced Leaﬂet Condition.
Criteria for balanced risk communication What does the leaﬂet report? What is unbalanced about it?
Completeness
Base risk 6700 women are diagnosed every year
1800 women  die of cervical cancer per year
Is mute about the references classes for incidence and
mortality  (out of 43 million German women = incidence: 0.01%,
mortality:  0.004%)
Beneﬁt  Vaccine is 98% effective for HPV types 16
and 18, which cause 70% of cervical cancer
Suggests that the vaccine would prevent almost 70% of all
cervical  cancers. Approval studies demonstrated an
effectiveness of 29% at most, which is not reported
Harms  Redness at injection site Does not mention any other harms and provides no numerical
information
Transparency  – Provides neither absolute numbers nor the reference class
Correctness/Evidence-based information – Does not mention the evidence from the approval studies
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If HPV vaccination; perceived risk of getting cervical cancer with-
ut the HPV vaccine; intention to have the HPV vaccine; and actual
ecision on HPV vaccination. To investigate each outcome, we ﬁled
he following questions: How many women out of 100,000 develop
ervical cancer every year? (up to 10, 100, 1000, more than 1000, I
on’t know); How many women  out of 100,000 die of cervical cancer
very year? (up to 10, 100, 1000, more than 1000, I don’t know); What
as the HPV vaccine been shown to prevent? (precancerous forms of
ervical cancer, cervical cancer, I don’t know); Out of 100,000 women,
ow many deaths from cervical cancer could be prevented by HPV
accination? (1, up to 10, 100, 1000, I don’t know); Tick all of the fol-
owing listed harms you think are associated with HPV vaccination
infertility, issues at the injection site, e.g.; swelling, redness, pain, sea-
onal allergies, unspeciﬁc pain or problems with the joints (arthritis),
reathing trouble/shortness of breath, hallucinations, none of these);
ow risky do you think it is to develop cervical cancer without hav-
ng the HPV vaccine? (not risky, not very risky, somewhat risky, very
isky, highly risky); Do you think that you would like to have the
PV vaccine? (yes, no, I am not sure); Has your daughter been vac-
inated for HPV in the meantime? (yes, no). The exact formulations
f the questions can be seen in the Appendix.
.3. AnalysisData were stored and analyzed using SPSS (version 18). If a
esponse was lacking for any outcome, it was coded as a missing
esponse. Because our outcome measures yielded ordinal data,
hich are not normally distributed, we used nonparametric
able 2
nformation provided in the leaﬂet developed for the balanced leaﬂet condition.
Criteria for balanced risk communication What does the leaﬂet report? 
Completeness
Base risk 15 women in 100,000 are diagnosed per
3  women  in 100,000 die of cervical canc
Beneﬁt  Incidence reduction: from 15 to 11 in 10
year  (=4 less in 100,000)
Mortality:  from 3 to 2 in 100,000 per ye
less in 100,000)
Harms  Very common (>10,000 in 100,000): fev
pain, and swelling at the injection site
Common (1000–10,000 in 100,000): sea
allergies
Rare (100–1000 in 100,000): unspeciﬁc
Transparency  Yes 
Correctness/Evidence-based information Yes Future  I or II
Does  not report that outcome measures were surrogate
markers, not actual cervical cancer
tests. All between-subject comparisons were analyzed with the
Mann–Whitney U test, and all within-subject comparisons were
analyzed with the Wilcoxon rank-sum test. The resulting z-values
of these nonparametric tests were converted into the effect
size measure r. The concordance between people’s vaccination
intention and their actual vaccination decision was  analyzed with
Spearman’s correlation. To transparently depict the effect that the
two formats of risk communication would have on the outcomes,
we further calculated the change from “before leaﬂet” to “after
leaﬂet” in absolute percentage points.
5. Results
5.1. Knowledge of cervical carcinoma
The majority of the participants largely overestimated or did
not know the incidence and mortality of cervical carcinoma before
reading the leaﬂet. Sixty-four percent of the girls and 27% of the
parents thought that at least 1000 or more women in 100,000 were
diagnosed with cervical carcinoma every year in Germany; 16% of
the girls and 30% of the parents said that they did not know how
many. Similarly, 61% of the girls and 36% of the parents believed
that women’s risk of dying from cervical cancer was  at least 100 in
100,000 or more. Table 3 shows how reading the leaﬂets changed
participants’ knowledge.
For  instance, reading the balanced leaﬂet increased the number
of girls who  arrived at a correct estimate of the incidence by 66%
points and decreased the number of girls who  overestimated the
What is balanced about it?
 year
er per year
Provides the base rate and the reference class
0,000 per
ar (=one
Provides the base rate and the absolute risk reduction
er, redness,
sonal
 arthritis
Provides numerical information on the most common harms
Each section provides information about the base rate,
reference  class, and risk reduction/increase. Information is
provided  as absolute numbers and the same reference class of
100,000 is used for all beneﬁts and harms
Numbers are based on the approval studies, and on data from
the  German Federal Agency of Statistics and the German
Standing Vaccination Committee (STIKO)
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Table  3
Changes (in absolute percentage points) in knowledge about the incidence and mortality of cervical cancer from before to after reading the leaﬂet.
Change in knowledge
about  incidence of
cervical  carcinoma
Effect size (95% CI) Change  in
knowledge about
mortality  of
cervical  carcinoma
Effect size (95% CI)
Correct estimates Overestimates Correct estimates Overestimates
Girls Unbalanced leaﬂet* 25−12.6% (n = 103) +24.3% (n = 103) r = −.11 (−.30; .09) −17.9% (n = 102) +26.8% (n = 102) r = −.21 (−.39; −02)
Balanced leaﬂet +65.7% (n = 118) −54.1% (n = 118) r = −.74 (−.81; − 65) +56.8% (n = 119) −46% (n = 119) r = −.67 (−.76; − 56)
Parent Unbalanced leaﬂet* –1.2% (n = 102) +9.4% (n = 102) r = .00 (−.19; .19) −1% (n = 102) +14.1% (n = 102) r = −.06 (−.25; + 13)
r = −.5
lity of
l
r
a
i
d
5
c
t
b
6
v
t
m
r
n
h
b
t
e
m
v
g
t
e
r
e
p
h
l
i
a
.
a
.
l
r
5
l
5
i
i
“
sBalanced leaﬂet +32.6% (n = 119) −15.5% (n = 119) 
* Colored boxes highlight decreases in knowledge about the incidence and morta
ikelihood of dying from cervical cancer by 46% points. In contrast,
eading the unbalanced leaﬂet decreased the number of girls who
rrived at a correct estimate of the incidence by 13% points and
ncreased the number of girls who overestimated the likelihood of
ying of cervical cancer by 27% points.
.2. Knowledge of the beneﬁt and harms of HPV vaccination
Furthermore, most participants did not know what the HPV vac-
ine has been shown to prevent (precancerous lesions), nor did
hey know how many deaths from cervical cancer could potentially
e prevented by having the vaccine (1 in 100,000). For instance,
2% of the girls and 63% of the parents stated that having the HPV
accine would certainly prevent cervical cancer, and 59% of all par-
icipants assumed that having the vaccine would prevent 100 and
ore deaths in 100,000.
The  effect of each leaﬂet on participants’ HPV vaccination-
elated knowledge is shown in Table 4. Both leaﬂets increased the
umber of girls who now correctly understood that the vaccination
as been shown to prevent precancerous lesions, whereas only the
alanced leaﬂet increased the number of parents who understood
his. The balanced leaﬂet further improved participants’ knowl-
dge about the beneﬁt of the vaccination (mortality reduction): 49%
ore girls and 48% more parents now gave a correct estimate of the
accine’s efﬁcacy. By contrast, participants in the unbalanced leaﬂet
roup, showed a decrease of knowledge and an increase in overes-
imation: 22% more girls and 10% more parents overestimated the
ffect of the vaccination on cervical cancer mortality after having
ead the unbalanced leaﬂet (see Table 4).
To learn about the impact of the leaﬂets on participants’ knowl-
dge of the HPV vaccination harms, we gave participants a list of
ossible harms after reading the leaﬂet and asked them to choose all
arms that would apply to the HPV vaccination. Out of the six harms
isted, three are actually linked to the HPV vaccination: issues at the
njection site (fever, redness, pain, and swelling), seasonal allergies,
nd unspeciﬁc arthritis. Seventy-six percent of the girls (95% CI:
68%, .83%) and 92% of the parents (95% CI: .86%, .95%) in the bal-
nced leaﬂet group as compared to 48% of the girls (95% CI: .38%,
57%) and 54% of the parents (95% CI: .45%, .64%) in the unbalanced
eaﬂet group were able to identify the three possible harms after
eading the respective leaﬂet.
.3. Perceived risk of developing cervical carcinoma
Participants were further asked before and after reading the
eaﬂet to indicate on a 5-point scale, ranging from 1 (“not risky”) to
 (“highly risky”), their perceived risk of developing cervical cancer
f they did not have the vaccination. When analyzing the change
n perceived risk, we combined the scale points “not risky” (1) and
not very risky” (2) into the category “low perceived risk” and the
cale points “very risky” (4) and “highly risky” (5) into the category0 (−.62; −.35) +33.4% (n = 121) −11.2% (n = 121) r = −.53 (−.65; −.39)
 cervical carcinoma after reading the leaﬂet.
“high  perceived risk”. “Somewhat risky” (3) was categorized as
“medium perceived risk”.
The  balanced leaﬂet reduced the perceived risk of getting cervi-
cal cancer without having the HPV vaccine by at least one category
(e.g., from medium to low risk) for 51% of the girls and 45% of
the parents (girls: r = −.59; parents: r = −.46). Results were mixed
for the unbalanced leaﬂet condition: For 26% of the parents, the
perceived risk increased by at least one category (r = −.38), but did
not change for the girls (95% CIs for effect size included zero).
5.4.  Intention to have the HPV vaccine
For the balanced leaﬂet group, reading the leaﬂet reduced girls’
intention to have the HPV vaccine by 8% points, from 33% to 25%
points (r = −.21), and their parents’ intention by 8% points, from
39% to 31% points (r = −.20). For the unbalanced leaﬂet group, girls’
intention to have the HPV vaccine increased by 40% points from 24%
to 64% points (r = −.60) and their parents’ intention by 19% points
from 45% to 63% (r = −.38), respectively.
5.5.  Actual vaccination decision
About 14 months after the initial part of the study, we inves-
tigated participants’ actual vaccination decision. We recontacted
132 of the 225 parents who  had originally agreed to participate
in this second wave (balanced: n = 67, unbalanced: n = 65). At ﬁrst
glance, the actual uptake of HPV vaccination did not differ between
the two  leaﬂet conditions (p = .93, r = .01): 22% of the parents in the
balanced leaﬂet group and 23% of the parents in the unbalanced
leaﬂet group reported that their daughter had had the HPV vac-
cine in the meantime. However, a 2 × 2 analysis on concordance
between vaccination intention and actual vaccination decision for
each group revealed that for 97% (rs = .92, p = .00) of the cases in the
balanced leaﬂet group but for only 60% (rs = 37, p = .08) of the cases
in the unbalanced leaﬂet group did the originally stated vaccination
intention also predict the eventual vaccination decision.
6.  Discussion
Between 86% and 95% of participants in the unbalanced leaﬂet
condition either overestimated the risk of cervical cancer and the
effectiveness of HPV vaccination by at least an order of magnitude
or did not know the answer to these questions after they had read
the information leaﬂet on HPV vaccination from the D. Krebshilfe
(German Cancer Aid). Contrary to the intention of this leaﬂet, it
instead reduced the number of people who correctly understood
the risk of cervical cancer and the effectiveness of the vaccination.
These ﬁndings add to the evidence that unbalanced reporting about
medical matters seriously misinforms people (e.g., [24–27].) The
balanced leaﬂet, in contrast, enhanced people’s understanding of
each of the investigated knowledge dimensions.
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Table 4
Changes (in absolute percentage points) in knowledge about the purpose and the beneﬁt of the HPV vaccine from before to after reading the leaﬂet.
Change in knowledge about
the purpose of HPV
vaccination
Effect  size (95% CI) Change  in knowledge
about  the beneﬁt of the
vaccine
Effect  size (95% CI)
Correct answer Correct estimates Overestimates
Girls Unbalanced leaﬂet* +13.9% (n = 102) r  = −.36 (−.52; .18) −5% (n = 102) +21.6% (n = 102) r = −.18 (−.27; −.12)
Balanced leaﬂet +27.5% (n = 121) r = −.47 (−.60; −.32) +48.5% (n = 120) −40.5% (n = 120) r = −.66 (−.77; −.55)
.02 (−
.37 (−
* y of ce
l
p
i
l
c
(
t
i
r
t
g
D
f
t
g
t
d
t
a
b
H
a
r
t
t
p
p
i
h
h
i
n
v
w
o
s
r
t
a
m
a
t
a
n
2
u
t
m
n
iParent Unbalanced leaﬂet* 0% (n = 103) r = −
Balanced leaﬂet +22.2% (n = 118) r = −
Colored boxes highlight decreases in knowledge about the incidence and mortalit
Because the unbalanced leaﬂet reported relative numbers (i.e.,
arge numbers) or numbers without a reference class, many more
eople judged their risk of developing cervical cancer without hav-
ng the vaccine to be considerably higher after having read the
eaﬂet than they had previously. Because the balanced leaﬂet, in
ontrast, reported all information in transparent absolute numbers
i.e., small numbers) accompanied by a reference class, many par-
icipants perceived their risk to be considerably lower and, in fact,
n more realistic numbers after reading the leaﬂet.
People’s altered risk perception did translate into the commonly
eported impact on people’s intention. We  saw a decrease in par-
icipants’ intention to have the HPV vaccine in the balanced leaﬂet
roup and an increase in intention in the unbalanced leaﬂet group.
espite these differences in intention, the two groups did not dif-
er in extent of the real uptake of HPV vaccination. At ﬁrst glance,
hese ﬁndings suggested that although the balanced information
roup now knew more about cervical cancer and the efﬁcacy of
he HPV vaccine than did the unbalanced information group, these
ifferences did not translate into a difference in actual vaccina-
ion behavior. Our study would not have been the ﬁrst to discover
 difference between people’s knowledge and their actual health
ehavior, the so-called knowledge–behavior gap (e.g., [19,20]).
owever, a closer inspection of our data revealed that the bal-
nced information apparently induced a preventive intention that
obustly predicted people’s actual vaccination behavior. By con-
rast, the increase in vaccination intention that was induced by
he unbalanced information did not reliably predict the partici-
ants’ eventual vaccination decision. These ﬁndings suggest that
henomena such as the knowledge–behavior gap more likely exist
f people are presented with unbalanced rather than balanced
ealth information. We  did not ﬁnd evidence on the use of the
euristic “trust-your-doctor” [23] in our data. For the participants
n the balanced leaﬂet group, we observed no increase from the
umber of people who stated their intention to have the HPV
accine to those who actually reported having had the vaccine,
hereas for the participants in the unbalanced leaﬂet group, we
bserved a pronounced decrease from the number of people who
tated their intention to have the HPV vaccine to those who  actually
eported having had the HPV vaccination.
Our results should be viewed in the light of a potential limita-
ion. The study was conducted at the beginning of 2010, three years
fter the HPV vaccination was ﬁrst ofﬁcially recommended by Ger-
an  health authorities and covered by German health plans for girls
ged 12–17 years. Between 2010 and today the quality of informa-
ion in patient leaﬂets and media may  have substantially improved,
nd hence it could be argued that the implication of our study may
o longer be up-to-date. However, Bodemer et al.’s analysis from
012 makes it clear that the current standard of information has
nfortunately not improved since the year in which we conducted
he study.At  the same time, the intentions of our study should not be
isconstrued. By no means do we wish to speak out against vacci-
ation or cast doubts on the beneﬁts of prevention. Prevention is an
mportant means of improving public health. However, in keeping.21; +.17) −1.0% (n = 99) +9.8% (n = 99) r = −.14 (−.33; +.06)
.51; −.21) +47.9% (n = 120) −42.1% (n = 120) r = −.64 (−.73; −.52)
rvical carcinoma after reading the leaﬂet.
with  evidence-based medicine and informed decision making,
we believe that it is important to inform people transparently
about what and what not to expect from a preventive measure
under consideration. Withholding information or providing only
favorable information ignores the ideal of contemporary medicine:
informed (not paternalistic) decisions. Moreover, such intranspar-
ent formats are recognized by people: When we asked participants
to evaluate the quality of the leaﬂet, three quarters of the parents
and nearly half of the girls in the unbalanced group stated that the
leaﬂet did not help them to understand the beneﬁt and harms of
the vaccination. In comparison, only 25% of the parents and 18% of
the girls in the balanced group found their leaﬂet uninformative.
We  can only speculate as to the reasons why  some public health
agencies provide patients with unbalanced health information. One
reason might be that the leaﬂet developers themselves struggle
with understanding which statistics are transparent and which
are not. Even many licensed medical doctors demonstrate limited
understanding of the statistics in their own  specialties [27–31,12].
In addition, the use of unbalanced health information might be
motivated by the assumption that exaggerating the threat of a dis-
ease will more likely encourage people to engage in preventive
behavior [32–34]. Our study, however, does not support this view.
Informed decisions require balanced information and balanced
numbers that quantify both beneﬁts and harms. Unfortunately,
none of the existing German leaﬂets on HPV vaccination [3,4] follow
the guiding principles of evidence-based risk communication. To
promote informed decision making and avoid the risk of losing
patients’ trust, German health agencies should incorporate these
principles and strive to provide transparent and balanced medical
information.
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Appendix A . Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.vaccine.2013.
12.038.
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